Real Chemistry announced Monday morning that it hired Sherry Pudloski as group president of client solutions and integrated communications.
The 2024 MM+M Agency 100 honoree stated that the industry veteran will serve as a strategic advisor to clients, including for tasks related to product and corporate communications, public affairs and investor relations, among others.
Pudloski most recently served as SVP and chief corporate affairs officer at Seagen, a position she has held since February 2023. During her time there, the Seattle-based, cancer-focused biotech was acquired by Pfizer in a $43 billion deal.
Prior to joining Seagen, Pudloski was principal consultant at SNP Communications; EVP and head of corporate affairs and communications at Zoetis; and chief communications officer at Guardian Life.
Earlier in her career, she held leadership roles at Pfizer, Novartis and Ogilvy PR, where she ran the agency’s global health practice.
Pudloski currently serves on the board of advisors for Jhpiego Corporation as well as vice chair of the board of trustees at Maryvale Preparatory School. She also founded the N.Y. Women’s Council and served as the U.S. chair for its Global Women’s Council.
“I am thrilled to join Real Chemistry at a time when AI is transforming health — from the discovery of new medicines to physician engagement to patient care and communications. Real Chemistry’s leading analytics, digital and creative capabilities make the firm an exceptional partner in delivering health engagement, activation and outcomes,” she said in a statement.
Pudloski joins the agency on the heels of another year of double-digit growth.
According to the 2024 MM+M Agency 100 revenue chart, Real Chemistry’s revenue grew 18% year-over-year to $608 million.
The agency’s headcount also ballooned to 2,110 full-timers following the acquisitions of med-comms shop Avant Healthcare and data/predictive analytics specialist TI Health.
Now, Pudloski brings her wealth of experience to deepen the agency’s considerable integrated comms bench.
“I’ve known Sherry for many years, and her profound commitment to excellence and innovation in healthcare communications is unmatched,” said Jennifer Gottlieb, global president of Real Chemistry, in a statement. “Sherry’s vision to pursue ‘what’s next’ in communications at what is a vibrant and exciting time for our industry, and the expertise she has gained from her in-house and client-side roles, give her the unique ability to see situations from the client’s perspective. That is core to who we are and have always been at Real Chemistry, with dozens of former clients working for many years with us. Sherry’s expertise will only further Real Chemistry’s position as the leading commercialization partner to the life sciences industry.”
